IOL CHEMICALS & PHARM. | PARMAX PHARMA | IOL CHEMICALS & PHARM./ PARMAX PHARMA |
|||
---|---|---|---|---|---|
P/E (TTM) | x | 13.2 | -2.6 | - | View Chart |
P/BV | x | 1.5 | 1.8 | 81.7% | View Chart |
Dividend Yield | % | 1.0 | 0.0 | - |
IOL CHEMICALS & PHARM. PARMAX PHARMA |
EQUITY SHARE DATA | |||||
---|---|---|---|---|---|
IOL CHEMICALS & PHARM. Mar-23 |
PARMAX PHARMA Mar-23 |
IOL CHEMICALS & PHARM./ PARMAX PHARMA |
5-Yr Chart Click to enlarge
|
||
High | Rs | 537 | 58 | 931.8% | |
Low | Rs | 272 | 26 | 1,033.0% | |
Sales per share (Unadj.) | Rs | 377.6 | 30.2 | 1,252.3% | |
Earnings per share (Unadj.) | Rs | 23.7 | -0.2 | -11,621.9% | |
Cash flow per share (Unadj.) | Rs | 31.6 | 3.5 | 906.8% | |
Dividends per share (Unadj.) | Rs | 4.00 | 0 | - | |
Avg Dividend yield | % | 1.0 | 0 | - | |
Book value per share (Unadj.) | Rs | 256.8 | 11.5 | 2,236.5% | |
Shares outstanding (eoy) | m | 58.71 | 5.10 | 1,151.2% | |
Bonus / Rights / Conversions | 0 | 0 | - | ||
Price / Sales ratio | x | 1.1 | 1.4 | 76.9% | |
Avg P/E ratio | x | 17.1 | -205.9 | -8.3% | |
P/CF ratio (eoy) | x | 12.8 | 12.1 | 106.2% | |
Price / Book Value ratio | x | 1.6 | 3.7 | 43.1% | |
Dividend payout | % | 16.9 | 0 | - | |
Avg Mkt Cap | Rs m | 23,743 | 214 | 11,089.6% | |
No. of employees | `000 | NA | NA | - | |
Total wages/salary | Rs m | 1,682 | 28 | 5,979.7% | |
Avg. sales/employee | Rs Th | 0 | 0 | - | |
Avg. wages/employee | Rs Th | 0 | 0 | - | |
Avg. net profit/employee | Rs Th | 0 | 0 | - |
INCOME DATA | |||||
---|---|---|---|---|---|
Net Sales | Rs m | 22,171 | 154 | 14,416.5% | |
Other income | Rs m | 256 | 0 | 64,025.0% | |
Total revenues | Rs m | 22,427 | 154 | 14,546.1% | |
Gross profit | Rs m | 2,257 | 23 | 10,007.5% | |
Depreciation | Rs m | 462 | 19 | 2,456.6% | |
Interest | Rs m | 165 | 4 | 4,451.4% | |
Profit before tax | Rs m | 1,887 | 0 | 410,108.7% | |
Minority Interest | Rs m | 0 | 0 | - | |
Prior Period Items | Rs m | 0 | 0 | - | |
Extraordinary Inc (Exp) | Rs m | 0 | 0 | - | |
Tax | Rs m | 495 | 2 | 33,006.7% | |
Profit after tax | Rs m | 1,391 | -1 | -133,788.5% | |
Gross profit margin | % | 10.2 | 14.7 | 69.4% | |
Effective tax rate | % | 26.2 | 326.5 | 8.0% | |
Net profit margin | % | 6.3 | -0.7 | -927.4% |
BALANCE SHEET DATA | |||||
---|---|---|---|---|---|
Current assets | Rs m | 9,667 | 75 | 12,839.0% | |
Current liabilities | Rs m | 5,025 | 71 | 7,041.1% | |
Net working cap to sales | % | 20.9 | 2.6 | 820.8% | |
Current ratio | x | 1.9 | 1.1 | 182.3% | |
Inventory Days | Days | 43 | 4 | 974.1% | |
Debtors Days | Days | 8 | 147,800 | 0.0% | |
Net fixed assets | Rs m | 11,017 | 97 | 11,372.2% | |
Share capital | Rs m | 587 | 45 | 1,319.0% | |
"Free" reserves | Rs m | 14,490 | 14 | 103,132.4% | |
Net worth | Rs m | 15,077 | 59 | 25,746.6% | |
Long term debt | Rs m | 0 | 45 | 0.0% | |
Total assets | Rs m | 20,684 | 176 | 11,743.5% | |
Interest coverage | x | 12.5 | 1.1 | 1,107.7% | |
Debt to equity ratio | x | 0 | 0.8 | 0.0% | |
Sales to assets ratio | x | 1.1 | 0.9 | 122.8% | |
Return on assets | % | 7.5 | 1.5 | 499.1% | |
Return on equity | % | 9.2 | -1.8 | -519.3% | |
Return on capital | % | 13.6 | 4.0 | 338.2% | |
Exports to sales | % | 26.7 | 0 | - | |
Imports to sales | % | 0 | 0 | - | |
Exports (fob) | Rs m | 5,930 | NA | - | |
Imports (cif) | Rs m | NA | NA | - | |
Fx inflow | Rs m | 5,930 | 0 | - | |
Fx outflow | Rs m | 6,052 | 0 | - | |
Net fx | Rs m | -122 | 0 | - |
CASH FLOW | |||||
---|---|---|---|---|---|
From Operations | Rs m | 1,223 | 3 | 36,717.7% | |
From Investments | Rs m | -1,200 | -9 | 12,820.5% | |
From Financial Activity | Rs m | -41 | NA | 9,340.9% | |
Net Cashflow | Rs m | -18 | -6 | 284.4% |
Indian Promoters | % | 48.2 | 30.8 | 156.3% | |
Foreign collaborators | % | 0.0 | 0.0 | - | |
Indian inst/Mut Fund | % | 1.7 | 0.0 | - | |
FIIs | % | 1.4 | 0.0 | - | |
ADR/GDR | % | 0.0 | 0.0 | - | |
Free float | % | 51.8 | 69.2 | 74.9% | |
Shareholders | 130,003 | 2,099 | 6,193.6% | ||
Pledged promoter(s) holding | % | 0.0 | 0.0 | - |
Compare IOL CHEMICALS & PHARM. With: DIVIS LABORATORIES CIPLA SUN PHARMA DR. REDDYS LAB ZYDUS LIFESCIENCES
No comparison is complete without understanding how the stock prices have performed over a period of time.
Here's a brief comparison:
Period | IOL CHEMICALS & PHARM. | PARMAX PHARMA | S&P BSE HEALTHCARE |
---|---|---|---|
1-Day | -1.10% | -8.89% | -0.44% |
1-Month | -4.43% | -7.42% | 2.15% |
1-Year | -4.01% | -7.66% | 49.82% |
3-Year CAGR | -11.98% | -11.92% | 14.21% |
5-Year CAGR | 15.37% | 10.65% | 19.19% |
* Compound Annual Growth Rate
Here are more details on the IOL CHEMICALS & PHARM. share price and the PARMAX PHARMA share price.
Moving on to shareholding structures...
The promoters of IOL CHEMICALS & PHARM. hold a 48.2% stake in the company. In case of PARMAX PHARMA the stake stands at 30.8%.
To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of IOL CHEMICALS & PHARM. and the shareholding pattern of PARMAX PHARMA.
Finally, a word on dividends...
In the most recent financial year, IOL CHEMICALS & PHARM. paid a dividend of Rs 4.0 per share. This amounted to a Dividend Payout ratio of 16.9%.
PARMAX PHARMA paid Rs 0.0, and its dividend payout ratio stood at -0.0%.
You may visit here to review the dividend history of IOL CHEMICALS & PHARM., and the dividend history of PARMAX PHARMA.
For a sector overview, read our pharmaceuticals sector report.
After opening the day deep in red, Indian share markets reversed the trend as the session progressed and ended on firm footing.